Therefore, to evaluate the effectiveness of albumin for patients with CS, we used the Medical Information Mart for Intensive Care IV (MIMIC-IV) database to assess whether resuscitation with combination albumin within 24 h after CS onset was associated with lower 30-day mortality. This evidence concerns the gene ALB and Cowden syndrome 1.